原发性硬化性胆管炎肝移植前后共有的黏膜肠道菌群特征
本研究纳入84例原发性硬化性胆管炎(PSC)、51例肝移植后PSC(PSC-LT)及40例健康对照,对回结肠活检组织行16S核糖体RNA基因(V3-V4)测序。PSC与PSC-LT个体内微生物多样性均低于健康对照,PSC-LT中变形菌门扩张更明显(相对丰度最高达19%,PSC最高11%,健康对照最高8%,Q FDR<0.05)。五种菌属与肝移植前后PSC均相关,基于这五种菌属的菌群失调指数及潜在致病菌克雷伯菌属与无肝移植生存期缩短相关。
要点
- PSC与肝移植后PSC患者个体内微生物多样性均低于健康对照。
- PSC-LT中变形菌门相对丰度最高达19%,高于PSC的11%与健康对照的8%(Q FDR<0.05)。
- 五种菌属与肝移植前后PSC均相关,菌群失调指数及克雷伯菌属与无肝移植生存期缩短相关。
核心结论
- 与PSC、PSC合并炎症性肠病及疾病严重程度相关的黏膜菌群特征在肝移植前后一致,支持平行研究PSC与复发性PSC,并提示应进一步研究肠道菌群对移植后肝脏健康的影响。
研究设计与样本
- 纳入84例PSC、51例肝移植后PSC(PSC-LT)患者及40例健康对照(HC),对回结肠活检组织行16S核糖体RNA基因(V3-V4)测序。
主要发现
- PSC与PSC-LT个体内微生物多样性均低于健康对照。
- 变形菌门扩张在PSC-LT更明显,相对丰度最高达19%,PSC最高达11%,健康对照最高达8%(Q FDR<0.05)。
- 在肝移植前(PSC vs 健康对照)与肝移植后(复发性PSC vs 无复发性PSC)比较中,PSC组均发现变异(离散度)增加。
- 五种菌属与肝移植前后PSC均相关;基于五种菌属计算的菌群失调指数及潜在致病菌克雷伯菌属的存在与无肝移植生存期缩短相关。
- 合并炎症性肠病与阿克曼菌属减少相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Several characteristic features of the fecal microbiota have been described in primary sclerosing cholangitis (PSC), whereas data on mucosal microbiota are less consistent. We aimed to use a large colonoscopy cohort to investigate key knowledge gaps, including the role of gut microbiota in PSC with inflammatory bowel disease (IBD), the effect of liver transplantation (LT), and whether recurrent PSC (rPSC) may be used to define consistent microbiota features in PSC irrespective of LT. APPROACH AND RESULTS: We included 84 PSC and 51 liver transplanted PSC patients (PSC-LT) and 40 healthy controls (HCs) and performed sequencing of the 16S ribosomal RNA gene (V3-V4) from ileocolonic biopsies. Intraindividual microbial diversity was reduced in both PSC and PSC-LT versus HCs. An expansion of Proteobacteria was more pronounced in PSC-LT (up to 19% relative abundance) than in PSC (up to 11%) and HCs (up to 8%; Q FDR < 0.05). When investigating PSC before (PSC vs. HC) and after LT (rPSC vs. no-rPSC), increased variability (dispersion) in the PSC group was found. Five genera were associated with PSC before and after LT. A dysbiosis index calculated from the five genera, and the presence of the potential pathobiont, Klebsiella , were associated with reduced LT-free survival. Concomitant IBD was associated with reduced Akkermansia . CONCLUSIONS: Consistent mucosal microbiota features associated with PSC, PSC-IBD, and disease severity, irrespective of LT status, highlight the usefulness of investigating PSC and rPSC in parallel, and suggest that the impact of gut microbiota on posttransplant liver health should be investigated further.
引用
- Hole MJ, Jørgensen KK, Holm K, et al. A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation. Hepatology. 2023. PMID: 36056902. doi:10.1002/hep.32773
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。